---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/300136754.md"
description: "Addex Therapeutics shares are trading higher after the company announced it regained full global rights to all GABAB positive allosteric modulator assets discovered under its research collaboration with Indivior UK."
datetime: "2026-09-25T12:28:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/300136754.md)
  - [en](https://longbridge.com/en/news/300136754.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/300136754.md)
generator: "portal-rs"
---

# 

Addex Therapeutics shares are trading higher after the company announced it regained full global rights to all GABAB positive allosteric modulator assets discovered under its research collaboration with Indivior UK.

### Related Stocks

- [ADXN.US](https://longbridge.com/en/quote/ADXN.US.md)
- [INDV.US](https://longbridge.com/en/quote/INDV.US.md)
- [INDV.UK](https://longbridge.com/en/quote/INDV.UK.md)

## Related News & Research

- [Supernus Pharmaceuticals Holds Special Stockholder Meeting](https://longbridge.com/en/news/302018511.md)
- [Addex regains global rights to GABAB PAM assets from Indivior](https://longbridge.com/en/news/300101287.md)
- [Addex Therapeutics Reports 2026 Half-Year Results  and Provides Corporate Update](https://longbridge.com/en/news/300254238.md)
- [APE: Raised USD 2.8M, regained GABAB PAM rights, and reported CHF 3.5M net loss for H1 2026](https://longbridge.com/en/news/300255769.md)
- [Addex Therapeutics (APE) Posts H1 Results; Raises $2.8M Post Period](https://longbridge.com/en/news/300254231.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**